ScreenerHero
HomeScreenerChartsCompareGroupsMapsCommoditiesWatchlists·PricingBlog
Create free account
Sign in
ScreenerHero

The most complete stock screener for serious investors. 18,000+ stocks across US, Canada, Europe & Australia.

All systems operational
Tools
  • Screener
  • Maps
  • Commodities
  • Charts
  • Watchlists
  • Alerts
  • Calendar
  • Portfolio
Screeners
  • US & Canada
  • Nordic
  • Benelux
  • Dividend EU
  • Value EU
  • Microcap EU
  • Small Cap EU
  • Investor screens
Compare
  • vs Stockopedia
  • vs Finviz
  • vs Koyfin
  • vs TradingView
  • All comparisons
  • Alternatives
Company
  • About
  • Coverage
  • Blog
  • Help
  • Pricing
  • Affiliate Program
  • Terms of Service
  • Privacy Policy
Screeners by countryUKGermanyFranceSpainItalyNetherlandsSwitzerlandSwedenNorwayDenmarkFinlandBelgiumAustriaPortugalPolandGreeceTurkeyRomaniaCanadaMexicoAustraliaNew Zealand
Deutsch·Français·Español·Italiano

For informational and educational purposes only. Not financial advice. Market participation involves substantial risk of loss. Past performance does not guarantee future results. Always do your own research.

© 2026 ScreenerHero.com · All rights reserved
ScreenerHero

CELU Celularity Inc.

NAS · US · Healthcare · Biotechnology · celularity.com
0.4630USD-1.05%Mkt Cap: 15.02M USDP/E: —2d ago

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.…

CELUCelularity Inc.
0.4630USD-1.05%

Industry Peers

Biotechnology
Screen all Biotechnology
VRTX
Vertex Pharmaceuticals Incorporated
$130.58BUSDP/E 33.1
REGN
Regeneron Pharmaceuticals, Inc.
$95.24BUSDP/E 20.4
MRNA
Moderna, Inc.
$78.90BUSD
CSL
CSL Limited
$63.11BUSD
ARGX
argenx SE
$58.94BUSDP/E 34.3
UCB
UCB SA
$58.59BUSDP/E 24.7
ARGX
argenx SE
$58.21BUSDP/E 32.1
ONC
BeOne Medicines AG
$44.66BUSDP/E 50.1
RPRX
Royalty Pharma plc
$39.36BUSDP/E 44.7
RVMD
Revolution Medicines, Inc.
$34.87BUSD
GMAB
Genmab A/S
$31.45BUSDP/E 46.1
GMAB
Genmab A/S
$31.20BUSDP/E 42.9
INSM
Insmed Incorporated
$31.01BUSD
ROIV
Roivant Sciences Ltd.
$28.01BUSD
INCY
Incyte Corporation
$23.36BUSDP/E 58.5
BNTX
BioNTech SE
$20.07BUSD
ALNY
Alnylam Pharmaceuticals, Inc.
$19.26BUSDP/E 7.3
ASND
Ascendis Pharma A/S
$16.58BUSDP/E 17.6
EXEL
Exelixis, Inc.
$15.77BUSDP/E 19.4
BBIO
BridgeBio Pharma, Inc.
$14.81BUSD